AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

TENAX THERAPEUTICS, INC. Director's Dealing 2021

Jun 15, 2021

34835_dirs_2021-06-15_8ca61920-8c7d-4243-9c28-d331f4b9635e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-02-25

Reporting Person: Davidson Michael H. (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	96645	Direct
Series B Preferred Stock	512	Direct